Therefore, the use of radiomics can aid in detecting these mutations before surgery, even if it has been demonstrated that TERT promoter mutations are tumor-related, and forecast patients’ prognosis, regardless of IDH status, despite showing, in some studies, lower accuracy compared to IDH and 1p/19q codeletion [7,8]. The gene discussed is IDH1; the disease is neoplasm.